放疗计划临床决策支持:数据驱动的机器学习策略用于患者特异性剂量学决策
本研究构建了一种临床决策支持系统,通过机器学习分类器利用患者特异性特征集和历史计划库,识别新患者可达到的既往已批准治疗计划。数据来自早期肺癌和术后口咽癌(光子及质子放疗),学习曲线显示早期肺癌约需45例、术后口咽光子约60例、术后口咽质子约30例患者即可获得足够准确的分类模型。该系统可早期告知临床医生关键结构间的剂量权衡,从而为个体患者优化治疗选择。
要点
- 机器学习分类器可匹配新患者与历史已批准计划,辅助治疗选择。
- 早期肺癌约需45例、术后口咽光子约60例、质子约30例达到足够准确分类。
- 系统可早期提示关键结构间的剂量权衡,优化个体化治疗决策。
核心结论
- 首次报道基于人工智能的临床决策支持系统,将患者与既往离散治疗计划连接,使临床医生能利用过去决策辅助当前评估。
研究设计与样本
- 收集早期肺癌及术后口咽癌(光子用于肺和头颈,质子用于头颈)的治疗数据,利用患者特异性特征集和历史计划库构建机器学习分类器,并用学习曲线分析模型准确性。
主要发现
- 学习曲线显示,早期肺癌、术后口咽光子、术后口咽质子分别约需45、60、30例患者即可获得足够准确的分类模型。
- 分类模型提供新患者可达到的既往已批准治疗计划数据库,示例展示在靶区剂量不变时心脏与胸壁剂量的权衡。
关键数值与推荐
- 早期肺癌约45例患者、术后口咽光子约60例患者、术后口咽质子约30例患者可达到足够准确的分类模型。
临床怎么用
- 临床医生可在治疗早期获知关键结构间的剂量权衡,从而有更多时间寻找个体患者的最佳治疗方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Clinical decision support systems are a growing class of tools with the potential to impact healthcare. This study investigates the construction of a decision support system through which clinicians can efficiently identify which previously approved historical treatment plans are achievable for a new patient to aid in selection of therapy. MATERIAL AND METHODS: Treatment data were collected for early-stage lung and postoperative oropharyngeal cancers treated using photon (lung and head and neck) and proton (head and neck) radiotherapy. Machine-learning classifiers were constructed using patient-specific feature-sets and a library of historical plans. Model accuracy was analyzed using learning curves, and historical treatment plan matching was investigated. RESULTS: Learning curves demonstrate that for these datasets, approximately 45, 60, and 30 patients are needed for a sufficiently accurate classification model for radiotherapy for early-stage lung, postoperative oropharyngeal photon, and postoperative oropharyngeal proton, respectively. The resulting classification model provides a database of previously approved treatment plans that are achievable for a new patient. An exemplary case, highlighting tradeoffs between the heart and chest wall dose while holding target dose constant in two historical plans is provided. CONCLUSIONS: We report on the first artificial-intelligence based clinical decision support system that connects patients to past discrete treatment plans in radiation oncology and demonstrate for the first time how this tool can enable clinicians to use past decisions to help inform current assessments. Clinicians can be informed of dose tradeoffs between critical structures early in the treatment process, enabling more time spent on finding the optimal course of treatment for individual patients.
引用
- Valdes G, Simone CB, Chen J, et al. Clinical decision support of radiotherapy treatment planning: A data-driven machine learning strategy for patient-specific dosimetric decision making. Radiother Oncol. 2017. PMID: 29162279. doi:10.1016/j.radonc.2017.10.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。